Transformative technology for tomorrow's medicine

MAT, or Multiomics Advanced Technology™ accelerates drug discovery, enhances personalized treatments, and predicts diseases with unprecedented speed and accuracy. It's not just technology; it's the future of medicine.

Technology

Pipeline

About

News

Contact

How it works

Built on advanced artificial intelligence technologies, MAT accurately simulates systems biology to expedite drug development and optimize treatments

GATC's Multiomics Advanced Technology (MAT) platform is the future of drug discovery and development. It can analyze 400 trillion data points in less than 8 minutes

11X Industry Standard

Validated increase in pre-clinical lead optimization over traditional processes and AI-assisted competitors, potentially saving pharmaceutical companies hundreds of millions of dollars and years of development per drug.

400 Trillion Data Points

Analyzes 400 trillion genetic datapoints (2,500 whole exomes) in less than 8 minutes

10-12 New Drugs a Year

Number of potential novel drug discoveries candidates per year – each potentially worth hundreds of millions of dollars.

Growing Patent Portfolio

Expanding patent portfolio includes drug candidates (neurology, oncology, metabolic, and autoimmune), predictive health reports, diagnostic tools and diagnostic technologies – all leveraging the MAT AI platform

Powering Through Data at Unmatched Speeds

Our platform analyzes a staggering 400 trillion genetic data points in less than 8 minutes. That's not just fast—that's revolutionary speed coupled with precision, driving healthcare into the future.

Setting a New Standard in Pre-Clinical Optimization

Our MAT platform outperforms the industry standard by 11 times, streamlining the drug development process. We're not just making small improvements; we're transforming the industry.

A Pipeline of Profitable Opportunities

With the capacity to produce an increasing number of new drug candidates each year, each potentially worth hundreds of millions, we are a powerhouse of innovation and opportunity.

De Novo Drug Discovery

We streamline the journey from discovery to pre-clinical testing, turning years into months.

Learn more

Drug Development

We de-risk the drug development process for pharmaceutical companies, offering support from pre-clinical stages to trials, and helping to repurpose or extend intellectual property.

Learn more

Risk Prediction

By simulating and validating causal biomarkers and pathways, MAT platform identifies the most promising treatment targets, enhancing drug safety and efficacy.

Learn more

GATC takes months ― not years ― to discover a new drug candidate

Contacts

Join Us in Transforming Medicine Through Advanced AI

We're always on the lookout for like-minded partners committed to making medicine better, more efficient, and safer. Reach out today to see how our specialized AI solutions can be tailored to your needs.